Clinical trial
SCREEN-HPV: Blood Biomarkers Based Screening for HPV-driven OPC
NCT06528353 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SCREEN-HPV: Blood Biomarkers Based Screening for HPV-driven OPC
- Lead sponsor
- UNICANCER
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- September 30, 2032
- Enrollment
- 10,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
anal cancer, head and neck squamous cell carcinoma, human papilloma virus